Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
On Thursday, Allscripts Healthcare (NASDAQ:MDRX) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.
Earnings and Revenue
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Allscripts earnings will be near 18 cents per share on sales of $523.54 million, according to analysts.
In the same quarter last year, Allscripts posted a loss of 14 cents per share on sales of $429.4 million. The analyst consensus estimate would represent a 28.57 percent increase in the company's earnings. Sales would be have grown 21.92 percent from the same quarter last year.
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
| Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
| EPS Estimate | 0.16 | 0.15 | 0.13 | 0.15 |
| EPS Actual | 0.16 | 0.15 | 0.13 | 0.14 |
Stock Performance
Over the last 52-week period, shares are up 17.22 percent. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The average rating by analysts on Allscripts stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
Don't be surprised to see the stock move on comments made during its conference call. Allscripts' Q4 conference call is scheduled to begin at 4:30 p.m. ET and can be accessed here.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.